Top Markets
Coin of the day
Avidity Biosciences Inc Avidity Biosciences Inc

Avidity Biosciences Inc

RNAM
Peringkat dalam Saham #2179
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Harga Saham
$71.34
Terakhir disinkronkan: 2026-03-03
Kapitalisasi Pasar
$9.84B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Avidity Biosciences Inc (RNAM)

Kategori

Riwayat hasil dividen untuk Avidity Biosciences Inc (RNAM)
Hasil dividen (TTM) dari Avidity Biosciences Inc (simbol saham: RNAM) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Avidity Biosciences Inc (RNAM) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH